Ansa Biotechnologies to Showcase DNA Synthesis Breakthrough at SynBioBeta 2026
Ansa Biotechnologies to Highlight Next-Generation DNA Synthesis Innovation with Industry-Exclusive On-Time Delivery Guarantee at SynBioBeta 2026 Ansa Biotechnologies, a biotechnology firm specializing in next-generation DNA synthesis solutions, has announced its…
Strand Therapeutics Names Kunal Bhatia as Chief Financial Officer
Strand Therapeutics Names Kunal Bhatia as Chief Financial Officer Strand Therapeutics, a clinical-stage biotechnology company focused on advancing programmable mRNA medicines, has announced the appointment of Kunal Bhatia as its…
Study Reveals Growing Public Optimism for Scientific Breakthroughs Alongside Increasing Concerns About the Pace of Global Change
Study Reveals Growing Public Optimism for Scientific Breakthroughs Amid Increasing Concerns Over the Pace of Global Change A new global report developed by Leaps by Bayer in collaboration with Boston…
Ray Therapeutics Secures European Medicines Agency PRIME Designation for RTx-015 in Retinitis Pigmentosa
Ray Therapeutics Secures PRIME Designation from the European Medicines Agency for RTx-015 Targeting Retinitis Pigmentosa Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company focused on developing innovative therapies for vision restoration,…
Masimo SET® Pulse Oximetry Shows Accurate Performance Across All Newborn Skin Tones in Landmark Study
Masimo SET® Pulse Oximetry Demonstrates Consistent Accuracy Across All Newborn Skin Tones in Largest-Ever Real-World Prospective Study Masimo has announced new clinical findings that reinforce the accuracy and reliability of…
Samsung Bioepis and ATLATL Enter MoU to Advance Early-Stage Biotech Innovation Across Asia-Pacific
Samsung Bioepis and ATLATL Enter MoU to Advance Early-Stage Biotech Innovation Across Asia-Pacific Samsung Bioepis Co., Ltd. has entered into a strategic collaboration with ATLATL Innovation Center to strengthen early-stage…
Vensica Medical Secures FDA IND Clearance for Phase 2 Trial of ViXe in Overactive Bladder
Vensica Medical Secures FDA IND Clearance to Launch Phase 2 Trial of ViXe, a Needle-Free Xeomin® Delivery System for Overactive Bladder Vensica Medical, an emerging innovator in the field of…
CareDx to Acquire Naveris, Expanding Leadership in Viral-Driven Cancer MRD Surveillance Testing
CareDx to Acquire Naveris, Expanding Leadership in Viral-Driven Cancer MRD Surveillance Testing CareDx, Inc., widely recognized for its focus on advancing precision medicine solutions in transplant care, has taken a…
CareDx Reports First Quarter 2026 Financial Results
CareDx Reports Financial Results for First Quarter 2026 CareDx Inc., a leading precision medicine company dedicated to improving outcomes for transplant patients, has reported strong financial results for the first…
Anova’s Global Urology Research Network Reaches Milestone with 500th Site Enrollment
Anova’s Global Urology Research Network Expands with Addition of 500th Urology Research Site Anova Enterprises, Inc. has announced a major expansion of its virtual urology research network, marking a significant…
Genexine’s First-in-Class SOX2 Degrader GX-BP1 Achieves Up to 96% Tumor Growth Inhibition and Prevents Regrowth in Preclinical Studies
Genexine’s First-in-Class SOX2 Degrader GX-BP1 Achieves Up to 96% Tumor Growth Inhibition and Prevents Regrowth in Preclinical Studies Genexine, Inc., a clinical-stage biotechnology firm focused on next-generation therapeutic platforms, has…
Global Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler to Enhance Patient Access and Navigation
Global Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler, Enhancing Patient Access and Transparency The Global Healthy Living Foundation (GHLF) has announced a new collaboration with Walgreens aimed at simplifying…